<DOC>
	<DOCNO>NCT03105817</DOCNO>
	<brief_summary>In post-dilution haemodiafiltration synthetic membrane use date . The allergy problem describe membrane require development membrane capable perform treatment . We describe vivo performance behaviour asymmetric cellulose triacetate ( ATA™ ) membrane , identify depurative effectiveness ease use clinical practice , well evaluate biocompatibility single haemodialysis session ( acute biocompatibility ) one month treatment ( chronic ) .</brief_summary>
	<brief_title>Cellulose Triacetate Dialyzer Hemodiafiltration-online</brief_title>
	<detailed_description>An interventional study perform 3 hemodialysis hospital unit ( La Princesa University Hospital , Príncipe de Asturias University Hospital Infanta Leonor University Hospital , Community Madrid , Spain ) usual dialyzer patient OLHDF replace Solacea™ dialyzer keep rest parameter unchanged . The study ( LIB 09/2015 ) review approve CEIC Príncipe de Asturias University Hospital . - Design study Each patient underwent 12 session haemodialysis usual schedule monitor : 5008 Fresenius ( n=14 ) , AK200US ( n=5 ) Artis Gambro ( n=3 ) DBB007 Nikkiso ( n=1 ) suitable OLHDF , although different convective transport control system . The nursing staff connect automatic OLHDF system . In case system Ultracontrol® ( Gambro monitor ) alarm PTM &gt; 300 mmHg system pressure ( PSist ) &gt; 700 mmHg appear solve , Ultracontrol® would withdraw pressure-control system would use . - Data collect : 1 . Demographic dialysis data - Demographic : sex , age , underlie disease , time OLHDF , type vascular access : fistula ( AFV ) catheter ( CT ) . - Dialysis Data : Monitor , dialysis fluid composition , sodium conductivity bicarbonate concentration , dialysis fluid flow ( Qd , ml min ) , liquid temperature , heparin type dosage . - Each dialysis session : effective time ( TE , min ) , blood flow ( Qb , ml min ) , ultra-filtrated volume achieve dry weight ( UF , l/session ) , Vinf ( l/session ) , infusion rate , ( Qi , ml/min ) Kt ( l / session ) , maximum PTM maximum Psist Ultracontrol® ( mmHg ) technical complication , alarm coagulation problem system may appear . The filtration fraction ( FF ) calculate percentage Qi relative Qb . The convective volume ( Vconv ) define total ultra-filtrated volume , sum VI UF.7 2 . Analytical determination 1 . Blood - On first last day study pre-dialysis sample take measurement monocyte , IL-6 IL-1β . - On interval day first week , 3 blood sample take : 1st ) beginning ( CI ) , 2nd ) 30 min ( CM ) 3rd ) end dialysis session ( CP ) . In CI CP follow parameter measure : haemoglobin , proteins albumin , urea , phosphorus , creatinine , uric acid , β2-microglobulin , myoglobin retinol transport protein ( RTP ) . Leukocytes , platelet , C3a C5a quantify CI CM . -- - Laboratory determination - General biochemical data : haemoglobin , protein , albumin , urea , phosphorus , reactive protein C ( PCR ) , creatinine uric acid , β2-microglobulin , myoglobin , ( RTP ) determine usual analyser hospital . - Determinations monocyte , complement , IL-6 IL-1β perform laboratory University Alcalá : - Activation plasma complement use sandwich ELISA : Determination C3a C5a activation perform platelet rich plasma sample use commercially available ELISA kit C3a Elabscience ( Wuhan , P.R . China ) ELISA C5a RayBiotech ( Norcross , Georgia ) . - Determination interleukin concentration serum use sandwich ELISA : IL-6 IL-1β concentration measure serum sample obtain whole blood store -80 ° C use . Both kit use supply Abcam ( Cambridge , UK ) - Determination monocyte subpopulation : The different subpopulation circulate monocyte peripheral blood identify flow cytometry ( FACSCalibur™ , Becton Dickinson , San Jose , CA , USA ) . First , monocyte population select accord size ( FSC/forward scatter ) granularity ( SSC/side scatter ) different subpopulation select double immunofluorescence accord stain anti-CD14 conjugate Tricolor ( monoclonal antibody TuK4 ) anti-CD16 conjugate FITC ( monoclonal antibody 3G8 ) . Both antibody respective isotype control purchase Life Technologies Invitrogen ( California , USA ) . The analysis perform Cyflogic program . - Calculations The percentage reduction ( RR ) calculate formula : RR ( % ) = [ ( Cpre - Cpos ) / Cpre ] x 100 , Cpre Cpos concentration analyse substance pre- post-dialysis . For protein bound substances β2-microglobulin concentration end session correct haemoconcentration correction factor ( FC ) base plasma protein concentration ( PT ) : FC = PTpre / PTpos , PTpre PTpos total concentration proteins pre-dialysis post-dialysis . -- - Statistical analysis All data collect database ( SPSS version 15 ) . Each value obtain average value obtain different session analytical determination . For statistical analysis , descriptive tool use , show average ( standard deviation ) , median , quartile percentage appropriate . For comparison two independent continuous variable , Student test pair sample use . For comparison two quantitative variable ANOVA test use . The p &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Inclusion Criteria : 18 year old , treat OLHDF 4 week 3 weekly session sign inform consent form . pregnancy illness would make patient 's death predictable le 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asymmetric cellulose triacetate</keyword>
	<keyword>Biocompatibility</keyword>
	<keyword>Hemodiafiltration on-line</keyword>
	<keyword>Convective volume</keyword>
	<keyword>Adequacy</keyword>
</DOC>